Company news
PAVmed Inc. news in 2024
PAVmed Inc.'s news releases, calls and decks from 2024, newest first.
PAVmed Provides Business Update and Third Quarter 2024 Financial Results
November 13, 2024
PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024
October 30, 2024
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care
October 9, 2024
PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements
September 15, 2024
PAVmed Provides Business Update and Second Quarter 2024 Financial Results
August 12, 2024
PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024
July 29, 2024
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
June 12, 2024
PAVmed Provides Business Update and First Quarter 2024 Financial Results
May 12, 2024
PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024
May 2, 2024
PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
April 29, 2024
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
March 25, 2024
PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX
March 20, 2024
PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024
March 12, 2024
Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors
February 7, 2024